Riskpilot← Back to searchSign inGet full accessMEDBAY AS
ASActiveOrg 990368589Tømtebakken 1A, 1396 BillingstadEconomic activity was not specified by tax authority · NACE 0000Est. 20060 employees
Revenue 2024
NOK 0
EBITDA margin
—
+56% vs 2023
Equity ratio
82.8%
Financial strength
Net profit 2024
NOK -24K
+64% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -30K | +56% |
| Net profit | NOK -24K | +64% |
| Total assets | NOK 786K | -14% |
| Equity | NOK 651K | -4% |
| Employees | 0 | — |
Legal name
MEDBAY AS
Org number
990368589
Legal form
Aksjeselskap
NACE code
0000 · Economic activity was not specified by tax authority
Founded
18. oktober 2006
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap. Styrets leder alene.
Company purpose
Virksomhet med utvikling og bestyrelse av forretningsideer samt investeringsvirksomhet, herunder å delta i andres selskaper og all virksomhet som dermed står i forbindelse, samt eie og forvalte fast eiendom.
Address
Tømtebakken 1A, 1396 Billingstad
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −32 | −28 | −25 | −68 | −30 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −32 | −28 | −25 | −68 | −30 |
| Net financials | 2 282 | 1 628 | −846 | −14 | −1 |
| Profit before tax | 2 250 | 1 600 | −871 | −82 | −31 |
| Tax | −0 | −0 | −0 | −15 | −7 |
| Net profit | 2 250 | 1 600 | −871 | −67 | −24 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 482 | 2 809 | 808 | 910 | 786 |
| Equity | 2 327 | 1 677 | 776 | 675 | 651 |
| Long-term debt | 0 | 0 | 0 | 127 | 102 |
| Short-term debt | 1 155 | 1 132 | 32 | 107 | 33 |
| Total debt | 1 155 | 1 132 | 32 | 234 | 135 |
EBITDA margin
-3008200.0%
This company
15.8%
Market median
-19039341% vs market
20202024
Equity ratio
82.8%
This company
38.2%
Market median
+117% vs market
20202024
Return on equity
-3.7%
This company
18.4%
Market median
-120% vs market
20202024
Net profit margin
-2396200.0%
This company
8.1%
Market median
-29582816% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.21×
This company
0.62×
Market median
+66% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TV Deputy Member | Deputy Member | 2006 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PV | Chairman | 2006 |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MEDBAY AS 
MEDBAY AS